FHA
SLXP

First Horizon Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

First Horizon Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-197
Closed -$30K – 1623
2014
Q3 		$30K Buy
197
+12
+6% +$1.74K ﹤0.01% 688
2014
Q2 		$25K Buy
185
+48
+35% +$5.31K ﹤0.01% 765
2014
Q1 		$14K Sell
137
-73
-35% -$7.47K ﹤0.01% 891
2013
Q4 		$20K Hold
210
– – ﹤0.01% 746
2013
Q3 		$14K Buy
+210
New +$14.5K ﹤0.01% 765

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Horizon Advisors's SLXP Position: Q4 2014 in Review

First Horizon Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 197 shares — an estimated $30K sold.

First Horizon Advisors first reported a position in SLXP in Q3 2013 and held it in 5 quarters. The position peaked at $30K in Q3 2014. 346 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • First Horizon Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
  • First Horizon Advisors sold 197 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $30K.
  • First Horizon Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 5 quarters.
  • First Horizon Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $30K in Q3 2014.
  • 346 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on First Horizon Advisors's 13F filing for Q4 2014, filed 5 Feb 2015.